Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

US Patent 11110303 · Granted Sep 7, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for targeting of treating neoplasms2015
Targeting cancer therapy combination2013
Combinations and methods for treating neoplasms2011
Combinations and methods for treating neoplasms2004